About products, innovations and the company

EUROIMMUN Launches Two Assays for the Quantification of SARS-CoV-2 Antibodies

Press release

CE-marked antibody tests expand EUROIMMUN’s comprehensive portfolio of laboratory products to support the analysis of the immune response to COVID-19

GynTect® – a new test procedure supplementing the EUROArray HPV

Reliable and fast diagnostics of cervical cancer

While HPV tests detect infections with HPV and thus allow drawing conclusions on the risk of developing cervical cancer, the GynTect® test can be used ...

Free public antibody testing in Böblingen: EUROIMMUN provides tests for pilot project in Southern Germany

Since 23 February 2022, residents of the district of Böblingen can receive one of 4000 free COVID-19 antibody tests offered by pharmacist Dr Björn Schittenhelm. By determining their antibody titers, ...

EUROLabPolaris – Trendsetting software for intelligently connected IIFT diagnostics

With its newly developed software platform “EUROLabPolaris” EUROIMMUN meets the demands in the increasingly globalised field of laboratory diagnostics by enabling large laboratory groups to work ...

EUROIMMUN and Homed-IQ offer Corporate COVID-19 Antibody Testing Program

With the Corporate COVID-19 Antibody Testing Program, EUROIMMUN gives companies the possibility to offer to their staff what EUROIMMUN has already offered to their own employees: an easy, ...

Exotic emerging diseases

Emerging infectious diseases is a term for new infectious diseases in humans that have either newly appeared in a population or have already existed but are rapidly increasing in incidence or ...

Christmas donations for charitable projects

Traditionally, Christmas is the time to reflect on what you have achieved and to turn your attention to those who are less well off.

The PerkinElmer Global Innovation Awards 2021 ceremony

For several weeks PerkinElmer, Inc. has been collecting nominations for a variety of Global Innovation Awards across all companies of the Group. EUROIMMUN has also suggested five colleagues from its ...

New guideline recognises anti-PLA2R as a significant biomarker for membranous nephropathy

In October 2021, the organisation KDIGO (Kidney Disease: Improving Clinical Outcomes) published an updated version of the clinical guideline for the management of patients with glomerulonephritis. ...

T cells: Important building blocks of immune protection against SARS-CoV-2

It is becoming increasingly clear that not only antibodies against SARS-CoV-2 play a role in building immunity against the coronavirus. T cells, as part of the cellular immune response, also have ...

Back to top
Contact person on site
Please click on a country or enter yours
North America
South & Central America
Middle East & Africa


Dear Visitor,

We'd like to use Hotjar, a service that helps us improve our website based on user behavior. Hotjar uses cookies to collect data about your device and behavior. This information is stored in a pseudonymized user profile.

Neither Hotjar nor we use this information to identify individual users. For more details, see Hotjar's Privacy Policy here.

If you agree, please click "Accept". You can withdraw your consent at any time. Thank you!

Necessary Cookies OnlyAccept